NCT03882606View on ClinicalTrials.gov

Implantation of SML in Patients With Dry Age-related Macular Degeneration and Myopic Maculopathy

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 22, 2019

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Age-Related Macular DegenerationLens, IntraocularMyopic Maculopathy
Interventions
DEVICE

Scharioth Macula Lens (SML, Medicontur)

magnifying intraocular lens for pseudophakic patients implanted in the ciliary sulcus in one eye of each patient

Trial Locations (1)

08227

Consorci Sanitari de Terrassa, Terrassa

All Listed Sponsors
collaborator

Medicontur Medical Engineering Ltd

INDUSTRY

lead

Consorci Sanitari de Terrassa

OTHER

NCT03882606 - Implantation of SML in Patients With Dry Age-related Macular Degeneration and Myopic Maculopathy | Biotech Hunter | Biotech Hunter